Literature DB >> 7566922

Carpal tunnel syndrome. Etiology and endoscopic treatment.

E Akelman1, A P Weiss.   

Abstract

Carpal tunnel syndrome involves classic symptoms of numbness and paresthesias in the radial three and one-half digits, most frequently nocturnal, with pain associated with this anatomic distribution. Thenar weakness and autonomic dysfunction occurs late in these patients and are usually seen in advanced cases. The wrist flexion test and local percussion sensitivity tests done on physical examination can be helpful in determining and confirming the diagnosis of carpal tunnel syndrome. The likelihood that operative treatment will be required for resolution of symptoms is heightened if the patient is involved in daily manual repetitive activities of the hand or wrist. Surgical decompression can be accomplished by either a limited open or new endoscopic carpal tunnel release techniques. Currently, the advantages and disadvantages present in both procedures and careful controlled studies conducted in a prospective and randomized fashion will be required to further delineate the indications for either procedure. Carpal tunnel release remains an operative procedure with the most predictable outcome with relief of symptoms for the patient.

Entities:  

Mesh:

Year:  1995        PMID: 7566922

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  3 in total

Review 1.  Carpal tunnel syndrome: modern diagnostic and management techniques.

Authors:  N Kanaan; R A Sawaya
Journal:  Br J Gen Pract       Date:  2001-04       Impact factor: 5.386

2.  Relationship Between Electrodiagnosis and Various Ultrasonographic Findings for Diagnosis of Carpal Tunnel Syndrome.

Authors:  Kyoung Moo Lee; Hyo Jong Kim
Journal:  Ann Rehabil Med       Date:  2016-12-30

3.  Comparison of clinical outcomes between open and modified endoscopic release for carpal tunnel syndrome.

Authors:  Zhong Chen; Jun Liu; Tang-Bo Yuan; Da-Wei Cai; Xiao-Xu Wang; Jian Qin
Journal:  Exp Ther Med       Date:  2021-06-10       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.